Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Fiber Optic Pressure Sensing Systems for Life Science Researchers

Published: Monday, November 11, 2013
Last Updated: Sunday, November 10, 2013
Bookmark and Share
New FISO-LS system designed for multi-use, non-disposable applications.

Harvard Apparatus has recently teamed up with FISO Technologies, Inc to introduce a new option for life science researchers with their fiber optic pressure sensing systems: FISO-LS.

FISO Technologies, Inc. has long been known for their clinical and industrial lines of fiber optic pressure sensors and has perfected the miniaturization of their clinical catheter line, commonly used in medical devices.

The new FISO-LS fiber optic pressure sensing system, specifically designed for life-science research and exclusively available from Harvard Apparatus in the United States and many other regions, is the first FISO pressure sensing system designed for multi-use, non-disposable applications.

The small sensors, at 300, 640 and 1000 micron diameters and pressure ranges of +/- 300 mmHg and 0-10 bar, are designed to be used in any pre-clinical physiological pressure measurement application.

Whether the researcher is measuring intracranial, gastro-intestinal, uro-genital, respiratory, spinal, intraocular, left ventricular pressure and more, the FISO-LS system is designed for accuracy.

As signal transduction does not rely on fluid-filled catheters, there is no need to be concerned with hydrostatic pressure columns, dampening by air bubbles, or the natural dampening of signal in fluid transduction.

The FISO sensors are the first to be mass-manufactured with the highest level quality assurance, allowing them to have a realistic price point in the current economic climate.

In short, this series of transducers is a welcome and much-needed addition to the researcher’s toolbox, allowing pressure sensing in areas previously too difficult or expensive to achieve.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Activating Cancer-Killing Immune Cells
A UCL research team have discovered that cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy cancer.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!